The answer appears to be ‘yes’ according a recent paper written by Uchechukwu Love Anyaduba, Oluwatosin Qawiyy Orababa, Zion Faye, Nazia Rashid, Gregory Reardon and myself. The abstract is below: BackgroundCancer trials increasingly use […]

We need to evaluate agentic AI through the specific lens of the healthcare industry and its workflows, evaluating the needs of providers, healthcare organizations as well as patients, recognizing that healthcare is not monolithic and will have […]

[Sponsored] Get your IV treatment from wherever you are. These top companies provide mobile IV therapy administered by experienced nurses in NYC and beyond. The post 5 Companies That Offer Mobile IV Therapy With Experienced Nurses in NYC and Beyond […]

Today’s healthcare industry is evolving, which highlights the essential need to adapt and adopt new technologies. Organizations that fully commit to digital transformation, prioritize robust data literacy and focus on pragmatic use cases for AI […]

[Sponsored] In an interview with MedCity News, Smarter Technologies CEO Jeremy Delinsky talked about the newly formed business Smarter Technologies and his ambition to automate hospitals’ revenue management capabilities with AI, which lags 2-5 […]

Apnimed’s obstructive sleep apnea drug reduced breathing interruptions in a Phase 3 clinical trial. The once-nightly pill, which is based on research from Brigham and Women’s Hospital, activates muscles that keep the upper airway open during […]

The new service at Prince Philip Dental Hospital is said to be the first of its kind in the world.

Also, Bangkok Hospital has started installing smart mirrors for contactless vital signs measurement. 

Also, The Clinician’s patient-reported measures platform is coming to Magentus’ marketplace.   

Ensuring buy-in from end users is critical to hospitals’ AI success. To achieve buy-in, hospitals should start by adopting AI tools that address the problems that physicians and nurses have identified as most important to them, said Rohit Chandra, […]

Fujirebio Diagnostics’ blood test for Alzheimer’s disease offers a less expensive and less invasive alternative compared to medical imaging and tests of cerebrospinal fluid. But competition looms from blood-based tests in development by other […]

WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn’t adapt fast enough to a rapidly changing weight-loss environment spurred by the rising popularity of GLP-1s, experts said. The post Why WeightWatchers Filed for […]

As the safety-net landscape shifts and funding uncertainty grows, the path forward is clear. By investing in highly coordinated, data-informed care and aligning health plans, providers and communities around shared goals, we can build a system that […]

As demand for trial sites increases, more investigators are overburdened or experiencing burnout. What can the industry do to help? The post Clinical Trials Have a Research Site Demand and Supply Crisis. Here is How to Solve it appeared first on […]

Without trust, the rapid adoption of AI in healthcare could stall, pointed out Joel Gordon, UW Health’s chief medical information officer. He urged healthcare leaders to focus less on flashy rollouts and more on governance, collaboration, and […]

Sprinter Health’s $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of the University of California, Google Ventures and Accel. The post Sprinter Health […]

Lakdawalla and Goldman. Tyler Cowen. AARP. National Pharmaceutical Council (from 2021) BIO. Adam Fein Here is a comparison of the CMS Final Rule (from 2021) vs. 2025 Trump Executive Order.

Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and […]

The combination will allow healthcare and life sciences companies to respond more efficiently to research questions.  

The company will use the funds to scale its technologies and expand its services.  

Perhaps the most significant health policy of our time, it revolutionized coverage and access, as well as the way healthcare companies communicated. With its future uncertain, now is the time to look back on how it shaped a new era of healthcare […]

Breakthroughs in synthetic biology could help accelerate advances in applications from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable […]

[Sponsored] The webinar, sponsored by PurpleLab and scheduled for May 22, will explore how healthcare sector companies can leverage real world data (RWD) with a focus on lung cancer. The post Using RWD to Improve Clinical Trial Recruitment, […]

There were lots of very interesting sessions at ISPOR 2025 in Montreal. One of my favorites that I was able to attend was titled “Medicare Price Negotiation of Part B Drugs: Implications for Provider Reimbursement and Commercial Spillover“. The […]

With Medbridge’s new motion capture capabilities, patients can get more accurate feedback on therapeutic exercises while using their mobile phone or computer’s camera. The post Medbridge Announces New AI-Powered Motion-Capture Capabilities for […]